Additionally, the classical pathogenesis of anemia in dialysis-dependent patients is usually associated with excessive PTH secretion and secondary hyperparathyroidism (HPTS) with subsequent fibrosis of bone marrow that could interfere with erythropoiesis and increase the required ESA dose.1 Here, PTH is linked to anemia (phenotype).